Cargando…
HOMA-IR index in non-diabetic patient, a reliable method for early diagnosis of liver steatosis
BACKGROUND: NAFLD is one of the most common liver diseases in the world. HOMA-IR as an indicator of insulin resistance is commonly used in clinical trials in NAFLD patients. The aim of this study was to evaluate the application of HOMA-IR index in the diagnosis of NAFLD. METHODS: This study was perf...
Autores principales: | Motamed, Behrang, Kohansal Vajargah, Mahsa, Kalantari, Saeed, Shafaghi, Afshin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Babol University of Medical Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348208/ https://www.ncbi.nlm.nih.gov/pubmed/35974947 http://dx.doi.org/10.22088/cjim.13.3.519 |
Ejemplares similares
-
Are HOMA-IR and HOMA-B good predictors for diabetes and pre-diabetes subtypes?
por: Khalili, Davood, et al.
Publicado: (2023) -
High HOMA-IR Index in Healthcare Shift Workers
por: Ledda, Caterina, et al.
Publicado: (2019) -
Prevalence of insulin resistance and identifying HOMA1-IR and HOMA2-IR indexes in the Middle Black Sea region of Turkey
por: Demir, Ayşe Kevser, et al.
Publicado: (2020) -
The HOMA-Adiponectin (HOMA-AD) Closely Mirrors the HOMA-IR Index in the Screening of Insulin Resistance in the Brazilian Metabolic Syndrome Study (BRAMS)
por: Vilela, Brunna Sullara, et al.
Publicado: (2016) -
Circulating Sphingolipids, Insulin, HOMA-IR, and HOMA-B: The Strong Heart Family Study
por: Lemaitre, Rozenn N., et al.
Publicado: (2018)